Literature DB >> 11056879

The antiemetic drug ondansetron interferes with lithium-induced conditioned rejection reactions, but not lithium-induced taste avoidance in rats.

C L Limebeer1, L A Parker.   

Abstract

Conditioned rejection reactions displayed in the taste reactivity test are exclusively produced by treatments that elicit nausea. The present experiments demonstrate that pretreatment with the antinausea agent ondansetron interferes with both the establishment and the expression of conditioned rejection reactions. Ondansetron did not interfere with lithium-induced taste avoidance in either a 1-bottle or a 2-bottle test. In fact, when rejection reactions were measured during a consumption test, ondansetron selectively attenuated rejection reactions, with only a slight modification of consumption. These results suggest that conditioned rejection reactions, but not conditioned taste avoidance, reflect nausea in rats that can be attenuated by ondansetron pretreatment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11056879     DOI: 10.1037//0097-7403.26.4.371

Source DB:  PubMed          Journal:  J Exp Psychol Anim Behav Process        ISSN: 0097-7403


  37 in total

1.  Anandamide transport inhibition by ARN272 attenuates nausea-induced behaviour in rats, and vomiting in shrews (Suncus murinus).

Authors:  L D O'Brien; C L Limebeer; E M Rock; G Bottegoni; D Piomelli; L A Parker
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

2.  Effects of the FAAH inhibitor, URB597, and anandamide on lithium-induced taste reactivity responses: a measure of nausea in the rat.

Authors:  Shelley K Cross-Mellor; Klaus-Peter Ossenkopp; Daniele Piomelli; Linda A Parker
Journal:  Psychopharmacology (Berl)       Date:  2006-11-17       Impact factor: 4.530

3.  Extinction of a saccharin-lithium association: assessment by consumption and taste reactivity.

Authors:  Raúl Cantora; Matías López; Luis Aguado; Shadna Rana; Linda A Parker
Journal:  Learn Behav       Date:  2006-02       Impact factor: 1.986

4.  The novel cannabinoid CB1 receptor neutral antagonist AM4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats.

Authors:  Kelly S Sink; Peter J McLaughlin; Jodi Anne T Wood; Cara Brown; Pusheng Fan; V Kiran Vemuri; Yan Peng; Yan Pang; Teresa Olszewska; Teresa Olzewska; Ganesh A Thakur; Alex Makriyannis; Linda A Parker; John D Salamone
Journal:  Neuropsychopharmacology       Date:  2007-06-20       Impact factor: 7.853

Review 5.  Cannabinoid CB1 receptor inverse agonists and neutral antagonists: effects on food intake, food-reinforced behavior and food aversions.

Authors:  John D Salamone; Peter J McLaughlin; Kelly Sink; Alexandros Makriyannis; Linda A Parker
Journal:  Physiol Behav       Date:  2007-04-14

6.  Nonreinforced flavor exposure attenuates the effects of conditioned taste aversion on both flavor consumption and cue palatability.

Authors:  Dominic Michael Dwyer; Patricia Gasalla; Matías López
Journal:  Learn Behav       Date:  2013-12       Impact factor: 1.986

7.  The effect of cannabidiol and URB597 on conditioned gaping (a model of nausea) elicited by a lithium-paired context in the rat.

Authors:  Erin M Rock; Cheryl L Limebeer; Raphael Mechoulam; Daniele Piomelli; Linda A Parker
Journal:  Psychopharmacology (Berl)       Date:  2007-11-09       Impact factor: 4.530

8.  Effect of combined doses of Δ(9)-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea using rat (Sprague- Dawley) models of conditioned gaping.

Authors:  Erin M Rock; Cheryl L Limebeer; Linda A Parker
Journal:  Psychopharmacology (Berl)       Date:  2015-09-18       Impact factor: 4.530

Review 9.  Conditioned taste aversion, drugs of abuse and palatability.

Authors:  Jian-You Lin; Joe Arthurs; Steve Reilly
Journal:  Neurosci Biobehav Rev       Date:  2014-05-09       Impact factor: 8.989

10.  Sensory Cortical Activity Is Related to the Selection of a Rhythmic Motor Action Pattern.

Authors:  Jennifer X Li; Joost X Maier; Emily E Reid; Donald B Katz
Journal:  J Neurosci       Date:  2016-05-18       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.